切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - DREADD Ligands - P-glycoprotein (P-gp) - 5-HT1 Receptors - Aurora Kinases

40件产品中的 11-20

页面
每页
清除全部
  1. Paliperidone
    A8496 Paliperidone
    中文名: 帕利哌酮
    Target: 5-HT2 Receptors|D2 Receptors|D3 Receptors|5-HT1 Receptors|Histamine H1 Receptors
    Summary: 多巴胺受体拮抗剂
      ≥10.662 mg/mL
      insoluble in H2O
  2. Sumatriptan Succinate
    A5294 Sumatriptan Succinate
    中文名: 舒马普坦琥珀酸盐
    Target: 5-HT1 Receptors
    Summary: 5-HT1受体激动剂
      ≥136.8 mg/mL
      ≥47.2 mg/mL
  3. TC-A 2317 hydrochloride
    A4489 TC-A 2317 hydrochloride
    Target: Aurora Kinases
    Summary: Aurora kinase A抑制剂
      <39.29 mg/mL
      <19.65 mg/mL
  4. Zosuquidar
    A3956 Zosuquidar
    Target: P-glycoprotein (P-gp)|Cytochrome P450 (CYP450)
    Summary: MDR调节剂
      Soluble in DMSO
  5. Vortioxetine
    A3926 Vortioxetine
    中文名: 沃替西汀
    Target: 5-HT1 Receptors|5-HT7 Receptors|5-HT3 Receptors|SERT
    Summary: 5-HT受体拮抗剂
      ≥14.92 mg/mL
      insoluble in H2O
  6. Tariquidar methanesulfonate, hydrate
    A3859 Tariquidar methanesulfonate, hydrate
    中文名: 他立喹达二甲磺酸盐六水合物
    Target: P-glycoprotein (P-gp)
    Summary: P-糖蛋白抑制剂
      ≥56.2 mg/mL
      insoluble in H2O
  7. Reversine
    A3760 Reversine
    中文名: 逆转素
    Target: Aurora Kinases
    Summary: Aurora激酶抑制剂
      ≥19.65 mg/mL
      insoluble in H2O
  8. Elacridar
    A3384 Elacridar
    中文名: 依克立达
    Target: P-glycoprotein (P-gp)
    Summary: BCRP抑制剂
      ≥56.4 mg/mL
      insoluble in H2O
  9. Clozapine N-oxide(CNO)
    A3317 Clozapine N-oxide(CNO)
     1 Citation
    中文名: 氯氮平的N-氧化物
    Target: DREADD Ligands
    Summary: Clozapine代谢产物,用于化学遗传学
      ≥17.15 mg/mL
      ≥49 mg/mL
  10. AZD1152
    A3214 AZD1152
     1 Citation
    Target: Aurora Kinases
    Summary: Aurora B激酶抑制剂
      ≥5.88 mg/mL
      insoluble in H2O

40件产品中的 11-20

页面
每页